## Abstract A new hepatobiliary contrast agent for magnetic resonance (MR) imaging, gadolinium‐ethoxybenzy1 (EOB)‐diethylemetriaminepentaacetic acid (DTPA), was compared with Gd‐DTPA to define the potential for improving tumor‐liver contrast in a rodent liver adenocarcinoma model. With a T1‐weighte
Comparison of three different injection methods for arterial phase of Gd-EOB-DTPA enhanced MR imaging of the liver
✍ Scribed by Tsutomu Tamada; Katsuyoshi Ito; Koji Yoshida; Akihiko Kanki; Atsushi Higaki; Daigo Tanimoto; Hiroki Higashi
- Book ID
- 116440841
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 339 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0720-048X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Purpose: To clarify the factors that predict enhancement of the liver parenchyma in hepatocyte‐phase of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd‐EOB‐DTPA)‐enhanced MR imaging. ## Materials and Methods: Gd‐EOB‐DTPA–enhanced hepatocyte‐phase MR images of 198 pa
## Abstract ## Purpose: 1) To analyze and compare fast dynamic imaging sequences to biopsy suspect liver lesions. 2) To evaluate the additional use of hepatocyte‐specific contrast agent compared to the nonenhanced fast dynamic scans and diagnostic liver imaging. ## Materials and Methods: Image a